Digital Transformation

Facing revenue decline from new regulations, Pet Service Holding partners with Figo to tap the booming, underserved European pet insurance market.

China's largest travel firm faces a dual crisis as a government antitrust probe erases billions in value, prompting a US law firm to investigate.

A new partnership aims to make life-saving cancer and anti-infective drugs stable at room temperature, revolutionizing global access and sustainability.

Merck's former R&D IT head Matt Studney joins TetraScience, a move highlighting biopharma's critical pivot from fragmented data to industrial-scale AI.

With record revenues projected for 2025, Vietnam's tourism sector is shifting from mass-market appeal to a sustainable, high-value future.

International Healthcare Week 2026 will unite pharma, medtech, and labs, aiming to transform healthcare for 700 million people across Southeast Asia.

AI pioneer H2O.ai secures renewed IMDA accreditation, validating its secure, air-gapped GenAI for Singapore's public and private sectors.

The Korean biopharma giant is leveraging its biosimilar success to fund a major push into cutting-edge cancer therapies and advanced drug platforms.

Ameriprise Financial's top rank on TIME's 'Iconic Companies' list reveals a story of strategic independence, tech innovation, and enduring reputation.

Lead Capital Partners' strategic investment in PedsOne signals a growing focus on specialized services that help independent doctors navigate financial pressures.

The digital marketing giant acquires GURU Conference and SubjectLine.com, betting on education and community to empower small businesses.

The firm's recognition highlights a market shift toward AI-driven quality assurance. What does this mean for enterprises seeking to innovate and reduce risk?

A Brazilian tech firm won a $1M prize for its groundbreaking AI that hears water leaks, tackling a global crisis and saving billions of liters daily.

Spire's upcoming Feb. 3 earnings call is under scrutiny as investors weigh a massive $11.2B investment plan against ambitious growth targets.

As Helmerich & Payne preps its Q1 2026 earnings call, investors are watching if its tech focus can overcome soft rig demand and cautious market signals.

Flashpoint Therapeutics appoints an FDA-approved drug developer as CSO, a strategic move to accelerate its groundbreaking structural nanomedicine platform.

A U.S. Appeals Court upheld a massive award to DXC Technology, finding Tata Consultancy Services willfully stole trade secrets in a landmark IP ruling.

The retail giant is fueling growth with a massive 2026 investment plan, targeting new stores, digital transformation, and a major push in the US market.

Following a relentless union campaign and deep staff cuts, Conestoga President John Tibbits has resigned, opening a new chapter of uncertainty and reform.

Lendmark's new Powhatan branch marks its 50th in Virginia, blending strategic growth with deep community and philanthropic commitments.